Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00362687
Status:
COMPLETED
Last Update Posted:
2009-03-31
First Post:
2006-08-09
Brief Title:
GMB Study of Truvada TDFFTC or Emtricitabine FTC Alone Versus HAART Interruption in HIV-Infected Patients With Resistance
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Organization Data
Organization:
Gilead Sciences
Class:
INDUSTRY
Study ID:
GS-ES-164-0151
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gilead Sciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Pedro Ferrer
Old Organization:
Gilead Sciences